| (Values in U.S. Thousands) | May, 2026 | May, 2026 | May, 2026 | May, 2026 | May, 2026 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | 0 | 0 | 0 | 0 | 0 |
| Net Income Growth | unch | unch | unch | unch | unch |
Pyng Medical Corp (PYNGF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Pyng Medical Corp., is in the business of producing and selling the FAST1 Intraosseous Infusion System, TPOD Pelvic Stabilizer, MAT Tourniquet, and developing FASTx Sternal Intraosseous Device, and CRIC Cricothyrotomy System. The FAST1 Intraosseous (IO) Infusion System provides quick vascular access to enable the rapid administration of drugs, medications, fluids, and blood to patients, which require emergency life-saving treatment. The T-POD Pelvic Stabilizer device provides treatment of pelvic fractures by binding the pelvis. The MAT Tourniquet is used by the wounded patient or initial responder to stop life threatening arterial bleeding.The Company sells its products directly and through distribution partners to military, hospital, emergency medical service, government agency, and law enforcement customers, in the United States, Europe and Australia. The Company and its subsidiary are subject to income taxes in Canada and U.S.A.